New drug GEn-1124 tested in just 6 men – first look at how body handles it
NCT ID NCT07185113
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase study tested a single oral dose of GEn-1124 in 6 healthy adult men. Researchers measured how the drug moves through the body and checked for any side effects. Participants stayed in the clinic for 2 days and received follow-up phone calls. The goal was to gather basic safety and processing information, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GEn-1124 (oral capsule)
What could go wrong
This is a very early, small study in just 6 healthy men. It only looks at how the drug moves through the body and basic safety, not whether it treats any disease. Many early-stage drugs never advance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
New Zealand Clinical Research (NZCR)
Christchurch, 8011, New Zealand